Elsevier Drug Discovery & Development Survey
Innovation and Performance: What’s data got to do with it?


With increasing drug price pressures and failure of the one-drug-fits-all model, pharmaceutical R&D is striving to develop more targeted drugs.

Commercial success hinges upon realizing the potential of data-driven innovation and development.

How are industry leaders driving business performance amidst big data? What are the leading practices for harnessing data to create innovative and new drugs and treatments? What are the common challenges and bottlenecks?

Help us deliver a comprehensive report by participating in a survey on current drug discovery and development practices. We’re exploring the topics of innovation, commercial performance, and data-driven drug development amongst industry R&D and drug discovery departments.

Participants of the survey will receive a free copy of key findings from the survey in June 2017. The survey should take approximately 15 minutes to complete.

All survey responses are anonymous so that responses are not associated with specific company names.

To receive the free report, you must complete the survey and be a professional with job responsibilities related to drug discovery and development in a pharmaceutical or biotech Company. A valid work email is required to receive the report.

By submitting this form you also agree to receive information relevant to your interests from Elsevier B.V. and its affiliates worldwide. You can opt-out at any time by following the instructions given in the email messages you receive.


Elsevier's R&D Solutions supporting 'Innovation and Performance: What’s data got to do with it?'

Reaxys

Drive successful early drug discovery by providing chemists the shortest path to relevant literature, patent information, valid compound properties, and experimental procedures.

Learn more about Reaxys
Contact a Reaxys expert

Reaxys Medicinal Chemistry

Achieve more efficient hit identification and lead optimization by providing chemists the shortest path to normalized compound–target affinity data and comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles.
Learn more about Reaxys Medicinal Chemistry
Contact a Reaxys Medicinal Chemistry expert

PharmaPendium

Make more informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs by providing researchers with searchable FDA/EMA drug approval documents and comparative drug safety data.
Learn more about PharmaPendium
Contact a PharmaPendium expert

Embase

Uncover drug-disease relationships and drug-drug interactions by increasing the discovery of biomedical evidence and providing comprehensive relevant, up-to-date biomedical information.

Learn more about Embase
Contact a Embase expert

Pathway Studio

Streamline target and biomarker identification and drug repurposing by providing biological researchers with greater insight into the mechanisms of disease and facilitating the interpretation of experimental data.
Learn more about Pathway Studio
Contact a Pathway Studio expert

Professional Services

Drive innovative pharmaceutical research by resolving challenges with data quality and integration and making data easier for researchers to compare, analyze, interpret and share.

Learn more about Professional Services
Contact a Professional Services expert

ScienceDirect

Help researchers understand the entire breadth of research surrounding a disease by helping them more effectively and efficiently search authoritative, full-text scientific, technical and health content.

Learn more about ScienceDirect
Contact a ScienceDirect expert

Scopus

Detect trends, find partnerships and identify experts to stay on the cutting edge of research through the world’s largest abstract and citation database of peer-reviewed literature, including tools to track, analyze and visualize research.
Learn more about Scopus
Contact a Scopus expert